Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DNV001 in primary hypercholesterolaemia or mixed hyperlipidaemia
NCT07391722Phase 2Not yet recruiting
- Start
- Feb 2026
- Primary completion
- Jun 2027
- Modality
- Conjugated siRNA, Chemically Modified siRNA
01
Overview
A Phase 2 trial of DNV001 in hypercholesterolemia, mixed dyslipidemia. Planned start Feb 2026; status: not yet recruiting.
02
Drugs
DNV001
03
Conditions
hypercholesterolemiamixed dyslipidemia
Beyond the preview
Go deeper on NCT07391722.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07391722.